secwatch.observer — SEC 8-K summary
======================================

Issuer:     Replimune Group, Inc. (REPL)
CIK:        0001737953
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001104659-26-002721
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Replimune files updated corporate presentation for J.P. Morgan; exhibit content not available
--------------------------------------------------------------------------------

- Company released updated corporate presentation on January 12, 2026.
- Presentation to be presented at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.
- Presentation covers recent business developments and clinical data for RP1 and RP2 programs.
- Exhibit 99.1 text was not provided, preventing detailed analysis of clinical or strategic updates.
- No specific financial or clinical figures were disclosed in the 8-K filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737953/000110465926002721/0001104659-26-002721-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737953/000110465926002721/tm262890d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-002721

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer